NCT05607004
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05607004
Title (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (EVANGELINE)
Acronym EVANGELINE
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Atossa Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
University of Arizona Tucson Arizona 85719 United States Details
California Research Institute Los Angeles California 90027 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
Northwestern University Chicago Illinois 60611 United States Details
St. Elizabeth Healthcare Edgewood Kentucky 41017 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Washington University School of Medicine St Louis Missouri 63110 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57105 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37204 United States Details
Baylor University Houston Texas 77054 United States Details
Bon Secours Cancer Institute Midlothian Virginia 23114 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field